• LAST PRICE
    43.3000
  • TODAY'S CHANGE (%)
    Trending Up0.7300 (1.7148%)
  • Bid / Lots
    43.3000/ 11
  • Ask / Lots
    43.3100/ 5
  • Open / Previous Close
    42.9000 / 42.5700
  • Day Range
    Low 42.7500
    High 43.3200
  • 52 Week Range
    Low 33.3300
    High 43.8400
  • Volume
    3,765,225
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 42.57
TimeVolumeGSK
09:32 ET8070142.94
09:34 ET3355142.87
09:36 ET1582942.865
09:38 ET1806842.825
09:39 ET1911742.815
09:41 ET1333842.81
09:43 ET1041942.8101
09:45 ET31844342.82
09:48 ET2498242.795
09:50 ET5259042.775
09:52 ET2794442.76
09:54 ET5234442.785
09:56 ET6024342.805
09:57 ET3093142.82
09:59 ET851742.84
10:01 ET1863742.83
10:03 ET1030642.835
10:06 ET4142642.865
10:08 ET2711142.91
10:10 ET4011742.915
10:12 ET1453542.96
10:14 ET1607642.985
10:15 ET4562843.015
10:17 ET1657443.015
10:19 ET1727743.095
10:21 ET2987943.085
10:24 ET1159543.06
10:26 ET1100543.075
10:28 ET1454843.055
10:30 ET1981743.085
10:32 ET1190743.095
10:33 ET1069343.14
10:35 ET862543.105
10:37 ET1442443.14
10:39 ET765743.12
10:42 ET1181443.125
10:44 ET813643.095
10:46 ET354443.09
10:48 ET1662343.125
10:50 ET1044843.135
10:51 ET1045643.109
10:53 ET816143.08
10:55 ET1466043.05
10:57 ET1341143.07
11:00 ET740043.045
11:02 ET1223643.01
11:04 ET901043.035
11:06 ET892643.035
11:08 ET1172343.07
11:09 ET869943.085
11:11 ET1646843.06
11:13 ET634743.075
11:15 ET1482443.065
11:18 ET482743.065
11:20 ET560243.045
11:22 ET10134443.115
11:24 ET11136943.14
11:26 ET1404443.125
11:27 ET1827443.1455
11:29 ET2725543.1414
11:31 ET3003743.105
11:33 ET3136743.165
11:36 ET9760643.13
11:38 ET1959043.155
11:40 ET845643.185
11:42 ET511243.235
11:44 ET1736543.2
11:45 ET584043.215
11:47 ET217343.215
11:49 ET626743.2
11:51 ET334243.2
11:54 ET644243.205
11:56 ET645543.22
11:58 ET610043.235
12:00 ET1300343.21
12:02 ET753043.245
12:03 ET1723543.215
12:05 ET1435643.22
12:07 ET565543.21
12:09 ET854843.18
12:12 ET731743.16
12:14 ET1241943.095
12:16 ET640143.135
12:18 ET901743.105
12:20 ET1087443.115
12:21 ET564043.12
12:23 ET883243.15
12:25 ET1458243.17
12:27 ET355543.185
12:30 ET695043.18
12:32 ET1679443.17
12:34 ET834043.205
12:36 ET1339343.145
12:38 ET403843.115
12:39 ET778943.125
12:41 ET577243.14
12:43 ET316243.15
12:45 ET327643.145
12:48 ET1070543.14
12:50 ET460243.15
12:52 ET498743.17
12:54 ET883643.16
12:56 ET770443.15
12:57 ET983143.14
12:59 ET1019743.15
01:01 ET90043.15
01:03 ET1355543.15
01:06 ET530543.16
01:08 ET552643.18
01:10 ET410043.18
01:12 ET995343.16
01:14 ET3294243.255
01:15 ET362843.2714
01:17 ET797643.275
01:19 ET1184243.275
01:21 ET458143.28
01:24 ET325843.285
01:26 ET650743.265
01:28 ET222143.285
01:30 ET993543.3
01:32 ET1123543.315
01:33 ET1390743.3
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGSK
GSK plc
88.3B
15.8x
+6.39%
United StatesBMY
Bristol-Myers Squibb Co
89.6B
-14.2x
+4.90%
United StatesSNY
Sanofi SA
126.2B
25.5x
+4.55%
United StatesPFE
Pfizer Inc
153.9B
-457.6x
-7.10%
United StatesNVS
Novartis AG
212.1B
22.1x
-5.59%
United StatesBAYRY
Bayer AG
28.8B
-9.5x
---
As of 2024-05-02

Company Information

GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. It has developed monoclonal antibodies to help treat different diseases. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes more than 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines include medicines for immune-mediated conditions. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases.

Contact Information

Headquarters
980 Great West RoadBRENTFORD, United Kingdom TW8 9GS
Phone
208-047-5000
Fax
208-047-7807

Executives

Independent Non-Executive Chairman of the Board
Jonathan Symonds
Chief Executive Officer, Executive Director
Emma Walmsley
Chief Financial Officer, Executive Director
Julie Brown
President - Corporate Development
David Redfern
President - Global Supply Chain
Regis Simard

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$88.3B
Revenue (TTM)
$38.5B
Shares Outstanding
2.1B
Dividend Yield
3.39%
Annual Dividend Rate
1.4657 USD
Ex-Dividend Date
02-22-24
Pay Date
04-11-24
Beta
0.66
EPS
$2.73
Book Value
$8.24
P/E Ratio
15.8x
Price/Sales (TTM)
2.3
Price/Cash Flow (TTM)
10.1x
Operating Margin
20.02%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.